Transcription of for BIKTARVY. BIKTARVY ...
{{id}} {{{paragraph}}}
Gilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY . BIKTARVY (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial Approval: 2018 WARNING: POST TREATMENT acute EXACERBATION OF HEPATITIS B See full prescribing information for complete boxed warning. Severe acute exacerbations of hepatitis B have been reported in patients who are coinfected with HIV-1 and HBV and have discontinued products containing emtricitabine (FTC) and/or tenofovir disoproxil fumarate (TDF), and may occur with discontinuation of BIKTARVY .
See full prescribing information for complete boxed warning. • Severe acute exacerbations of hepatitis B have been reported in patients who are coinfected with HIV -1 and
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Drug, Patients, KDIGO Clinical Guidelines for Management of, Kidney, In patients, Drug-induced peptic ulcer disease, N-acetylcysteine) Hydration Oral NAC dosing, N-acetylcysteine) + Hydration Oral NAC dosing, Radiology Reimbursement Information Setting:, Radiology Reimbursement Information Setting: Hospital Outpatient